User login
VIDEO: Risks for anastomotic leak after colectomy identified
SAN FRANCISCO– A large retrospective study identified risk factors for anastomotic leak within 30 days of colectomy.
The analysis of data on 13,684 patients looked at a multicenter cohort, compared with previous smaller studies that generally focused on single institutions, Dr. Emily F. Midura and her associates reported at the annual clinical congress of the American College of Surgeons.
In a video interview at the meeting, Dr. Midura described the risk factors identified in the study.
The 4% of patients who developed a leak averaged 13 days in the hospital, compared with 8 days for patients with no leak, said Dr. Midura of the University of Cincinnati. A total of 6% of patients who developed an anastomotic leak died, compared with a 2% mortality rate in patients without a leak.
Indications for colectomy included cancer in 42% of patients, diverticulitis in 23%, inflammatory bowel disease in 6%, and other reasons in the rest of the cohort.
Dr. Midura reported having no financial disclosures.
The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
On Twitter @sherryboschert
SAN FRANCISCO– A large retrospective study identified risk factors for anastomotic leak within 30 days of colectomy.
The analysis of data on 13,684 patients looked at a multicenter cohort, compared with previous smaller studies that generally focused on single institutions, Dr. Emily F. Midura and her associates reported at the annual clinical congress of the American College of Surgeons.
In a video interview at the meeting, Dr. Midura described the risk factors identified in the study.
The 4% of patients who developed a leak averaged 13 days in the hospital, compared with 8 days for patients with no leak, said Dr. Midura of the University of Cincinnati. A total of 6% of patients who developed an anastomotic leak died, compared with a 2% mortality rate in patients without a leak.
Indications for colectomy included cancer in 42% of patients, diverticulitis in 23%, inflammatory bowel disease in 6%, and other reasons in the rest of the cohort.
Dr. Midura reported having no financial disclosures.
The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
On Twitter @sherryboschert
SAN FRANCISCO– A large retrospective study identified risk factors for anastomotic leak within 30 days of colectomy.
The analysis of data on 13,684 patients looked at a multicenter cohort, compared with previous smaller studies that generally focused on single institutions, Dr. Emily F. Midura and her associates reported at the annual clinical congress of the American College of Surgeons.
In a video interview at the meeting, Dr. Midura described the risk factors identified in the study.
The 4% of patients who developed a leak averaged 13 days in the hospital, compared with 8 days for patients with no leak, said Dr. Midura of the University of Cincinnati. A total of 6% of patients who developed an anastomotic leak died, compared with a 2% mortality rate in patients without a leak.
Indications for colectomy included cancer in 42% of patients, diverticulitis in 23%, inflammatory bowel disease in 6%, and other reasons in the rest of the cohort.
Dr. Midura reported having no financial disclosures.
The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
On Twitter @sherryboschert
AT THE ACS CLINICAL CONGRESS
Hospitalist Pioneer Bob Wachter Warns Waste Reduction Is New Quality Focus
Dr. Wachter closed SHM's 2013 annual meeting in National Harbor, MD, with a keynote address that identified cost and waste reduction as new planks of hospitalist's value proposition.
Dr. Wachter closed SHM's 2013 annual meeting in National Harbor, MD, with a keynote address that identified cost and waste reduction as new planks of hospitalist's value proposition.
Dr. Wachter closed SHM's 2013 annual meeting in National Harbor, MD, with a keynote address that identified cost and waste reduction as new planks of hospitalist's value proposition.
Evidence-Based Medicine Guru Implores Hospitalists to Join Cause
Gordon Guyatt, MD, who coined the term evidence-based medicine in a 1992 JAMA article, outlined EBM principles and challenged hospitalists to challenge the research.
Gordon Guyatt, MD, who coined the term evidence-based medicine in a 1992 JAMA article, outlined EBM principles and challenged hospitalists to challenge the research.
Gordon Guyatt, MD, who coined the term evidence-based medicine in a 1992 JAMA article, outlined EBM principles and challenged hospitalists to challenge the research.
Bob Wachter Says Cost Equation Is Shifting in Ever-Changing Healthcare Paradigm
HM pioneer says hospitalists who have flown under radar soon will be counted on to produce cost, waste reduction.
HM pioneer says hospitalists who have flown under radar soon will be counted on to produce cost, waste reduction.
HM pioneer says hospitalists who have flown under radar soon will be counted on to produce cost, waste reduction.
Hospitalists Flock to Annual Meeting's Bedside Procedures Pre-Courses
From early-career hospitalists looking to gain hands-on experience with intraosseous lines to family-medicine trained physicians brushing up on ultrasound usage, the procedures' pre-courses at SHM annual meetings receive rave reviews.
From early-career hospitalists looking to gain hands-on experience with intraosseous lines to family-medicine trained physicians brushing up on ultrasound usage, the procedures' pre-courses at SHM annual meetings receive rave reviews.
From early-career hospitalists looking to gain hands-on experience with intraosseous lines to family-medicine trained physicians brushing up on ultrasound usage, the procedures' pre-courses at SHM annual meetings receive rave reviews.
The Extracorporeal C-Incision Tissue Extraction (ExCITE) technique
As a result of recent concerns regarding the use of power morcellation, clinicians have been faced with the need to develop alternative techniques for contained tissue extraction during minimally invasive gynecologic procedures such as myomectomy and hysterectomy.
The following video represents a refined and reproducible approach that incorporates a containment bag (Anchor Medical) and a self-retaining retractor (Applied Medical) in order to meet the following objectives:
- tissue extraction without the need for power morcellation
- specimen containment to avoid intraperitoneal spillage
- ability to continue to offer minimally invasive surgical options to patients through a safe and standardized approach to tissue extraction.
The example case is real-time, contained, intact removal of an 8-cm, 130-g fibroid.
I hope you enjoy the featured opening session on best tissue extraction standards at the AAGL Global Congress on Minimally Invasive Gynecology in Vancouver and stop by to visit me at the OBG Management booth.
— Dr. Arnold Advincula, AAGL 2014 Scientific Program Chair
Share your thoughts on this video! Send your Letter to the Editor to [email protected]. Please include your name and the city and state in which you practice.
As a result of recent concerns regarding the use of power morcellation, clinicians have been faced with the need to develop alternative techniques for contained tissue extraction during minimally invasive gynecologic procedures such as myomectomy and hysterectomy.
The following video represents a refined and reproducible approach that incorporates a containment bag (Anchor Medical) and a self-retaining retractor (Applied Medical) in order to meet the following objectives:
- tissue extraction without the need for power morcellation
- specimen containment to avoid intraperitoneal spillage
- ability to continue to offer minimally invasive surgical options to patients through a safe and standardized approach to tissue extraction.
The example case is real-time, contained, intact removal of an 8-cm, 130-g fibroid.
I hope you enjoy the featured opening session on best tissue extraction standards at the AAGL Global Congress on Minimally Invasive Gynecology in Vancouver and stop by to visit me at the OBG Management booth.
— Dr. Arnold Advincula, AAGL 2014 Scientific Program Chair
Share your thoughts on this video! Send your Letter to the Editor to [email protected]. Please include your name and the city and state in which you practice.
As a result of recent concerns regarding the use of power morcellation, clinicians have been faced with the need to develop alternative techniques for contained tissue extraction during minimally invasive gynecologic procedures such as myomectomy and hysterectomy.
The following video represents a refined and reproducible approach that incorporates a containment bag (Anchor Medical) and a self-retaining retractor (Applied Medical) in order to meet the following objectives:
- tissue extraction without the need for power morcellation
- specimen containment to avoid intraperitoneal spillage
- ability to continue to offer minimally invasive surgical options to patients through a safe and standardized approach to tissue extraction.
The example case is real-time, contained, intact removal of an 8-cm, 130-g fibroid.
I hope you enjoy the featured opening session on best tissue extraction standards at the AAGL Global Congress on Minimally Invasive Gynecology in Vancouver and stop by to visit me at the OBG Management booth.
— Dr. Arnold Advincula, AAGL 2014 Scientific Program Chair
Share your thoughts on this video! Send your Letter to the Editor to [email protected]. Please include your name and the city and state in which you practice.
VIDEO: What works now and what’s up next for laser treatments of vascular malformations
LAS VEGAS – Pulsed dye lasers have stood the test of time for treating vascular malformations, rosacea, and telangectases, Dr. Christopher Zachary said at Skin Disease Education Foundation’s annual Las Vegas dermatology seminar.
However, Dr. Zachary noted in an interview at the meeting that the field of laser therapy is on the cusp of new innovation, not only in devices, but also in how the devices are used. Different wavelengths and combination treatments will provide more options for patients, he explained. “These are great times for those who are interested in treating vascular problems,” he said.
Dr. Zachary disclosed serving as a consultant for Cutera and Zeltiq, on the speakers bureau for Cynosure and Solta, and on the advisory board for Zeltiq.
SDEF and this news organization are owned by Frontline Medical Communications.
The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
LAS VEGAS – Pulsed dye lasers have stood the test of time for treating vascular malformations, rosacea, and telangectases, Dr. Christopher Zachary said at Skin Disease Education Foundation’s annual Las Vegas dermatology seminar.
However, Dr. Zachary noted in an interview at the meeting that the field of laser therapy is on the cusp of new innovation, not only in devices, but also in how the devices are used. Different wavelengths and combination treatments will provide more options for patients, he explained. “These are great times for those who are interested in treating vascular problems,” he said.
Dr. Zachary disclosed serving as a consultant for Cutera and Zeltiq, on the speakers bureau for Cynosure and Solta, and on the advisory board for Zeltiq.
SDEF and this news organization are owned by Frontline Medical Communications.
The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
LAS VEGAS – Pulsed dye lasers have stood the test of time for treating vascular malformations, rosacea, and telangectases, Dr. Christopher Zachary said at Skin Disease Education Foundation’s annual Las Vegas dermatology seminar.
However, Dr. Zachary noted in an interview at the meeting that the field of laser therapy is on the cusp of new innovation, not only in devices, but also in how the devices are used. Different wavelengths and combination treatments will provide more options for patients, he explained. “These are great times for those who are interested in treating vascular problems,” he said.
Dr. Zachary disclosed serving as a consultant for Cutera and Zeltiq, on the speakers bureau for Cynosure and Solta, and on the advisory board for Zeltiq.
SDEF and this news organization are owned by Frontline Medical Communications.
The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
AT SDEF LAS VEGAS DERMATOLOGY SEMINAR
VIDEO: Benzoyl peroxide hits the shower
LAS VEGAS – Benzoyl peroxide can be particularly effective on truncal acne when used as short contact therapy, Dr. Linda Stein Gold said at Skin Disease Education Foundation’s annual Las Vegas dermatology seminar.
In an interview at the meeting, Dr. Stein Gold explained how she has changed her practice with regard to benzoyl peroxide for some of her acne patients.
Dr. Stein Gold disclosed relationships with multiple pharmaceutical companies including Galderma, Stiefel, Allergan, Valeant, Ranbaxy, Promius, and Actavis.
SDEF and this news organization are owned by Frontline Medical Communications.
The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
LAS VEGAS – Benzoyl peroxide can be particularly effective on truncal acne when used as short contact therapy, Dr. Linda Stein Gold said at Skin Disease Education Foundation’s annual Las Vegas dermatology seminar.
In an interview at the meeting, Dr. Stein Gold explained how she has changed her practice with regard to benzoyl peroxide for some of her acne patients.
Dr. Stein Gold disclosed relationships with multiple pharmaceutical companies including Galderma, Stiefel, Allergan, Valeant, Ranbaxy, Promius, and Actavis.
SDEF and this news organization are owned by Frontline Medical Communications.
The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
LAS VEGAS – Benzoyl peroxide can be particularly effective on truncal acne when used as short contact therapy, Dr. Linda Stein Gold said at Skin Disease Education Foundation’s annual Las Vegas dermatology seminar.
In an interview at the meeting, Dr. Stein Gold explained how she has changed her practice with regard to benzoyl peroxide for some of her acne patients.
Dr. Stein Gold disclosed relationships with multiple pharmaceutical companies including Galderma, Stiefel, Allergan, Valeant, Ranbaxy, Promius, and Actavis.
SDEF and this news organization are owned by Frontline Medical Communications.
The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
AT SDEF LAS VEGAS DERMATOLOGY SEMINAR
VIDEO: Don’t discount topical therapy for psoriasis
LAS VEGAS– Don’t underestimate the value of topical therapy for treating psoriasis patients, Dr. Linda Stein Gold said at Skin Disease Education Foundation’s annual Las Vegas dermatology seminar.
Dr. Stein Gold explained how to overcome some of the compliance issues associated with topical therapies for psoriasis, and offered her suggestions for managing side effects in an interview at the meeting.
Dr. Stein Gold disclosed relationships with multiple pharmaceutical companies including Galderma, Stiefel, Allergan, Valeant, Ranbaxy, Promius, and Actavis.
SDEF and this news organization are owned by Frontline Medical Communications.
The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
LAS VEGAS– Don’t underestimate the value of topical therapy for treating psoriasis patients, Dr. Linda Stein Gold said at Skin Disease Education Foundation’s annual Las Vegas dermatology seminar.
Dr. Stein Gold explained how to overcome some of the compliance issues associated with topical therapies for psoriasis, and offered her suggestions for managing side effects in an interview at the meeting.
Dr. Stein Gold disclosed relationships with multiple pharmaceutical companies including Galderma, Stiefel, Allergan, Valeant, Ranbaxy, Promius, and Actavis.
SDEF and this news organization are owned by Frontline Medical Communications.
The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
LAS VEGAS– Don’t underestimate the value of topical therapy for treating psoriasis patients, Dr. Linda Stein Gold said at Skin Disease Education Foundation’s annual Las Vegas dermatology seminar.
Dr. Stein Gold explained how to overcome some of the compliance issues associated with topical therapies for psoriasis, and offered her suggestions for managing side effects in an interview at the meeting.
Dr. Stein Gold disclosed relationships with multiple pharmaceutical companies including Galderma, Stiefel, Allergan, Valeant, Ranbaxy, Promius, and Actavis.
SDEF and this news organization are owned by Frontline Medical Communications.
The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
AT SDEF LAS VEGAS DERMATOLOGY SEMINAR
